Advertisement

Topics

Latest "Societe Chimie Industrielle" News Stories

12:08 EST 13th December 2017 | BioPortfolio

Here are the most relevant search results for "Societe Chimie Industrielle" found in our extensive news archives from over 250 global news sources.

More Information about Societe Chimie Industrielle on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Societe Chimie Industrielle for you to read. Along with our medical data and news we also list Societe Chimie Industrielle Clinical Trials, which are updated daily. BioPortfolio also has a large database of Societe Chimie Industrielle Companies for you to search.

Showing "Societe Chimie Industrielle" News Articles, all 18

Relevant

PHILOGEN ANNONCE UN PARTENARIAT DE RECHERCHE AVEC SERVIER DANS LE DOMAINE DE LA CHIMIE ENCODÉE PAR ADN

Friday, August 25th 2017 at 6:00am UTC SIENNE, Italie–(BUSINESS WIRE)– Philogen S.p.A, une société de biotechnologie, a annoncé aujourd’hui, par l’intermédiaire de sa filiale Suisse, Philochem AG, un partenariat avec Servier. Cette collaboration porte sur la découverte de nouvelles petites molécules thérapeutiques au moyen de la plateforme ESAC, propriété de Philoc...


Klage gegen Sanochemia wegen Patentverletzung

Die Guerbet Societe Anonyme wirft der börsennotierten Sanochemia - wie auch drei weiteren Unternehmen - eine Patentverletzung vor. "Nach Durchsicht der Klageunterlagen und erster rechtlicher Einsch...

New green solvent could help clean our air

(Springer) French researchers have patented an eco-friendly liquid mixture that could help trap harmful pollutants from the air. The non-flammable solvent contains urea and choline salt, a common ingredient in chicken feed, says Leila Moura of the Unité de Chimie Environnementale et Interactions sur le Vivant in France. She is the lead author of a study in Springer's journal Environmental Chemist...


SocGen senkt Ziel für ExxonMobil auf 95 US-Dollar - 'Buy'

Die französische Großbank Societe Generale (SocGen) hat das Kursziel für die Aktien des Ölkonzerns ExxonMobil von 105 auf 95 US-Dollar gesenkt, die Einstufung aber auf "Buy" belassen. Dies schrieb...

SocGen belässt GlaxoSmithKline auf 'Sell' - Ziel 1075 Pence

Die französische Großbank Societe Generale (SocGen) hat die Einstufung für GlaxoSmithKline auf "Sell" mit einem Kursziel von 1075 Pence belassen. Der Pharmakonzern arbeite an zu vielen Dingen glei...

SocGen senkt Ziel für Merck KGaA auf 101 Euro - 'Hold'

Die französische Großbank Societe Generale (SocGen) hat das Kursziel für Merck KGaA von 103 auf 101 Euro gesenkt und die Einstufung auf "Hold" belassen. Dies schrieb Analyst Florent Cespedes in ei...

SocGen hebt Ziel für Novo Nordisk auf 212 Kronen - 'Sell'

Die französische Großbank Societe Generale (SocGen) hat das Kursziel für Novo Nordisk nach Zahlen zum dritten Quartal von 200 auf 212 dänische Kronen angehoben, aber die Einstufung auf "Sell" bela...

Diaxonhit : Acquisition de la société de diagnostic médical GENBIO aux Etats-Unis

Diaxonhit — Wednesday, July 19th 2017 at 3:45pm UTC DIAXONHIT annonce l’acquisition de la société GENBIO aux Etats-Unis Acquisition stratégique d’une entreprise commerciale pour accélérer le développement du groupe aux Etats-Unis, tout en renforçant son catalogue de produits propriétaires et son chiffre d’affaires GENBIO, une société de diagnostic médical qui pr...

Societe Adwya SA ADWYA Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummarySociete Adwya SA Societe Adwya is a manufacturer of external suspension solutions that markets nasal bulb drinkable solutions and suspension solutions. The company offers generics products. It provides products in therapeutics areas of analgesia, cardiology, endocrinology, gastroenterology, infectiology, central nervous system and urology, among others. Societe Adwya operates through two pr...

Societe Adwya SA ADWYA Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummarySociete Adwya SA Societe Adwya manufactures and markets external suspension solutions and nasal bulb drinkable solutions. The company offers generics and licensed products. It provides products in therapeutics areas of analgesia, cardiology, endocrinology, gastroenterology, infectiology, central nervous system and urology. Societe Adwya has two production sites, such as Alpha that manufactu...

Probably Relevant

GUERBET : Nombre d’actions et de droits de vote composant le capital de la société au 31 août 2017

GUERBET — Friday, September 15th 2017 at 3:00pm UTC Communiqué de presseVillepinte, le 15 septembre 2017 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l’article L. 233-8 II du code de commerce et de l’article 222-12-5 du règlement général de l’AMF, les sociétés dont des … Cet article GUE...

GUERBET : Nombre d’actions et de droits de vote composant le capital de la société au 31 juillet 2017

GUERBET — Wednesday, August 9th 2017 at 3:33pm UTC Communiqué de presseVillepinte, le 9 août 2017 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l’article L. 233-8 II du code de commerce et de l’article 222-12-5 du règlement général de l’AMF, les sociétés dont des … Cet article GUERBET :...

Societe des Industries Pharmaceutiques de Tunisie SA SIPHA Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummarySociete des Industries Pharmaceutiques de Tunisie SA SIPHAT is a drug manufacturing company that manufactures and markets generic drugs. The company provides generic drugs in therapeutic areas such as allergology, analgesicantipyretic, antihypertensive, antiinflammatory, antispasmodics, cardiology and angiology, dermatology, gastroenterology. It offers drug therapeutic area such as hepatolo...

Societe des Industries Pharmaceutiques de Tunisie SA SIPHA Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummarySociete des Industries Pharmaceutiques de Tunisie SA SIPHAT manufactures and markets generic drugs. The company offers generic drugs in therapeutic areas such as allergology, analgesicantipyretic, antihypertensive, antiinflammatory, antispasmodics, cardiology and angiology, dermatology, gastroenterology, hepatology, infectiology, metabolism and nutrition, neurology, pulmonology, rhumatologi...

Possibly Relevant

Biomillenia Leverages QIAGEN Bioinformatics in Microbiome-on-a-Chip Discovery of Unculturable Microbes

Collaboration data presented at 3rd Annual European Microbiome Congress Microbiome-on-a-chip technology capable of culturing, screening and isolating bacteria in single step while demonstrating targeted benefits QIAGEN’s Microbial Genomics Pro Suite enables analysis of microbial sequences and microbiomes ...

BIO World Congress on Industrial Biotechnology Returns to Montreal

Programming is open to members of the media Biotechnology Innovation Organization (BIO): WHAT: The Biotechnology Innovation Organization (BIO) will host the 2017

PET Preforms Market by Type Type 1, Type 2, Type 3, Type 4, Type 5, Application Carbonated Soft Drinks, Water, Food, NonCarbonated Drinks, Cosmetics Chemicals, Pharma Liquor, and Region Global Forecast to 2022 [Report Updated: 11072017] Prices from USD

PET preforms market to grow at a CAGR of 5.31% 20172022The global PET preforms market is projected to reach USD 23.35 billion by 2022, at a CAGR of 5.31% between 2017 and 2022. The increased demand for PET preforms in different applications, such as carbonated soft drinks, water, food oil/sauces, cosmetics chemicals, pharma liquor, and others acts as a key driving factor influencing the growth o...

Transgene: First Half-Year 2017 in Line with Our Objectives: All Clinical Programs Progressing and New Collaboration Agreements Signed

Regulatory News: Seven active clinical trials: First patients treated in four combination trials assessing TG4010 (lung cancer) or Pexa-Vec (liver cancer and other solid tumors) Two collaboration agreements signed with: Bristol-Myers Squibb, for a...


Quick Search
Advertisement
 

News Quicklinks